Primary Sjögren's syndrome: central and peripheral nervous system involvements.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Historique:
received: 10 08 2020
accepted: 14 09 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 28 10 2020
Statut: ppublish

Résumé

Primary Sjögren's syndrome (pSS) is a common systemic autoimmune disease characterised by exocrinopathy resulting in dryness of the mouth and eyes, unexplained fatigue and diffuse pain. Neurological involvement is uncommon in pSS, involving the central nervous system in 2-5% of cases and more frequently the peripheral nervous system in 5-15% of cases. The diagnosis of pSS is to be considered when confronted with symptoms such as mouth and eye dryness, fatigue and pain, the most frequent of pSS symptoms. Objective measures of oral and eye dryness may help assert the diagnosis of pSS, as well as ACR/EULAR criteria. Differential diagnoses have to be excluded in patients exhibiting neurological symptoms, such as cryoglobulinaemic vasculitis or multiple sclerosis, before considering a neurological involvement specific to pSS. The treatment of these neurological manifestations takes into account different parameters, such as the presence of cryoglobulinaemic vasculitis, the severity of the symptoms, a rapidly progressing evolution and the failure of previous symptomatic treatments.

Identifiants

pubmed: 33095149
pii: 16286

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-109

Auteurs

Arsène Mekinian (A)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France. arsene.mekinian@aphp.fr.

Juliette Tennenbaum (J)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France.

Constance Lahuna (C)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France.

Azzedine Dellal (A)

Hôpital Montfermeil, Service de Médecine Interne et Rhumatologie, Montfermeil, France.

Nabil Belfeki (N)

Hôpital de Melun, Service de Médecine Interne, Melun, France.

Jean Capron (J)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Neurologie, Paris, France.

Edouard Januel (E)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Neurologie, Paris, France.

Bruno Stankoff (B)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Neurologie, Paris, France.

Sonia Alamowitch (S)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Neurologie, Paris, France.

Olivier Fain (O)

Sorbonne Université, AP-HP, Hôpital Saint-Antoine, Service de Médecine Interne and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH